Auro Laboratories Ltd.
BSE: 530233 | Sector: Health care |
NSE: N.A. | ISIN Code: INE292C01011 |
BSE 15:40 | 23 May | 98.90 |
3.10 (3.24%) |
OPEN
98.95 |
HIGH
99.00 |
LOW
95.05 |
NSE 05:30 | 01 Jan | Auro Laboratories Ltd |
OPEN | 98.95 |
PREVIOUS CLOSE | 95.80 |
VOLUME | 3671 |
52-Week high | 195.00 |
52-Week low | 87.00 |
P/E | 15.77 |
Mkt Cap.(Rs cr) | 62 |
Buy Price | 97.10 |
Buy Qty | 20.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Auro Laboratories Ltd. (AUROLABS) - Yearly Result
Particulars (![]() |
Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 |
Net Sales/Income From Operations | 54.25 | 43.79 | 46.82 | 40.79 | 35.47 |
Other Income | 0.76 | 0.97 | 0.96 | 0.51 | 0.53 |
Total Income | 55.01 | 44.76 | 47.78 | 41.31 | 36.01 |
Total Expenditure | 43.01 | 37.52 | 39.98 | 34.56 | 31.15 |
Operating Profit | 12.00 | 7.24 | 7.80 | 6.75 | 4.86 |
Interest | 0.46 | 0.58 | 0.72 | 1.09 | 1.07 |
Gross Profit | 11.54 | 6.67 | 7.08 | 5.66 | 3.79 |
Depreciation | 1.04 | 1.02 | 1.01 | 0.93 | 0.86 |
PBT | 10.50 | 5.63 | 6.07 | 4.72 | 2.93 |
Tax | 3.20 | 1.52 | 1.62 | 1.27 | 0.59 |
Net Profit/(Loss) | 7.18 | 4.05 | 4.40 | 3.53 | 0.82 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 7.18 | 4.05 | 4.40 | 3.53 | 0.82 |
Equity Share Capital | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 |
Reserves Excluding Revaluation Reserves | 22.35 | 15.27 | 11.18 | 6.75 | 3.18 |
EPS | |||||
Basic EPS | 11.52 | 6.51 | 7.06 | 5.66 | 1.31 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Auro Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices